Hongwei Li
- Oncology top 10%
- Lung Cancer Research Studies 12
- Pancreatic and Hepatic Oncology Research 3
- Cancer Cells and Metastasis 3
-
- Brain Metastases and Treatment 10
- Lung Cancer Treatments and Mutations 10
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Lung Cancer Diagnosis and Treatment 3
-
- Immunotherapy and Immune Responses 3
Hongwei Li
45 papers receiving 533 citations
Peers
Comparison fields: 5 of 82
- Oncology 244
- Pulmonary and Respiratory Medicine 223
- Cardiology and Cardiovascular Medicine 96
- Cancer Research 62
- Surgery 116
Countries citing papers authored by Hongwei Li
This map shows the geographic impact of Hongwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei Li more than expected).
Fields of papers citing papers by Hongwei Li
This network shows the impact of papers produced by Hongwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei Li. The network helps show where Hongwei Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongwei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 12 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 7 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 4 | |
| 12 | 2020 | 3 | |
| 13 | 2020 | 8 | |
| 14 | 2017 | 4 | |
| 15 | 2017 | 4 | |
| 16 | TCM Syndrome Differentiation and Treatment Based on Invigorating Spleen for Patients with Stage IIIC Gastric Cancer after Curative Surgery | 2016 | 0 |
| 17 | 2015 | 3 | |
| 18 | 2015 | 13 | |
| 19 | 2013 | 131 | |
| 20 | 2006 | 36 |
About Hongwei Li
Hongwei Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Complementary and Manual Therapy, having authored 47 papers that have together received 535 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (12 papers), Brain Metastases and Treatment (10 papers), Lung Cancer Treatments and Mutations (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer Cells and Metastasis (3 papers), Immunotherapy and Immune Responses (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (244 citations), Pulmonary and Respiratory Medicine (223 citations) and Cardiology and Cardiovascular Medicine (96 citations). Hongwei Li has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Jiawei Chen, Yongquan Wu, Yongliang Wang, Shumei Zhao, Jianzhong Cao, Chenghong Peng, Weili Wang, Baiyong Shen, Jing Qian and Zelai He. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.